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Endometriosis, defined as the growth of endometrial tissue outside the uterus, is a common gynecologic condition affectingmillions
of women worldwide. It is an inflammatory, estrogen-dependent complex disorder, with broad symptomatic variability, pelvic pain,
and infertility being themain characteristics. Ovarian endometriomas are frequently developed in womenwith endometriosis. Late
diagnosis is one of the main problems of endometriosis; thus, it is important to identify biomarkers for early diagnosis. The aim
of the present work is to evaluate the ecto-nucleotidases activities in the contents of endometriomas. These enzymes, through the
regulation of extracellular ATP and adenosine levels, are key enzymes in inflammatory processes, and their expression has been
previously characterized in human endometrium. To achieve our objective, the echo-guided aspirated fluids of endometriomaswere
analyzed by evaluating the ecto-nucleotidases activities and compared with simple cysts. Our results show that enzyme activities
are quantifiable in the ovarian cysts aspirates and that endometriomas show significantly higher ecto-nucleotidases activities
than simple cysts (5.5-fold increase for ATPase and 20-fold for ADPase), thus being possible candidates for new endometriosis
biomarkers. Moreover, we demonstrate the presence of ecto-nucleotidases bearing exosomes in these fluids. These results add up
to the knowledge of the physiopathologic mechanisms underlying endometriosis and, open up a promising new field of study.
1. Introduction
Endometriosis is a chronic condition characterized by the
presence of endometrial tissue (stroma and glands) outside
the uterine cavity,mostly on pelvic peritoneum and ovaries. It
affects up to 15% of women of reproductive age and its preva-
lence is rising. It is an inflammatory, estrogen-dependent
complex disorder, with broad symptomatic variability, pelvic
pain, and infertility being the main characteristics. Both
symptoms are thought to be the result of an excessive
inflammatory environment not onlywithin the pelvis but also
in the eutopic endometrium, affecting implantation [1, 2].
It is one of the principal causes of infertility in women.
Late diagnosis is one of the main problems of this pathology,
taking between five and ten years from detection of the first
symptoms. Therefore, there is a need to identify biomarkers
for early diagnosis of endometriosis [3].
Ovarian endometriomas occur in 17–44% of patients
affected by endometriosis [4] and account for 35% of benign
ovarian cysts. Endometriomas are also called endometriotic
or “chocolate cysts” because of the internal fluid blood
derived dark color [5]. Although the risk of malignant
transformation is low, 0.6–0.8% [6], surgery has become the
gold standard therapy. Nowadays, laparoscopic cystectomy is
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the most extended treatment for endometriomas, although
fertility could be afterwards compromised. Some studies
have reported a lower ovarian reserve after excision of
ovarian endometriomas due to incidental excision of normal
ovarian tissue together with the endometrioma wall [7, 8].
There is also evidence of a significant postoperative decrease
in circulating Anti-Mu¨llerian hormone, a commonly used
biomarker for ovarian reserve quantification, suggesting a
negative impact on ovarian reserve after the excision of
endometriomas [8]. Therefore, a new minimally invasive
interventional technique was implemented to treat low risk
malignancy ovarian cysts, including endometriomas, the
ultrasound-guided aspiration followed by sclerosis, which
seems to have even a low recurrence risk (0–15%) [9–
13]. The sclerosis does not seem to have consequences on
the number of pregnancies, term pregnancies, abortions,
extracted oocytes, embryo quality, and hormonal levels if
compared with infertile women without ovarian cysts [11, 14].
The analysis of the contents of endometriomas can help
identify new biomarkers for this pathology. For example,
endometriotic cysts contain significantly more iron than
other ovarian cysts; this has been suggested as a possible
cause of carcinogenesis in endometriomas through iron-
induced persistent oxidative stress [15]. Proteomic analysis
of follicular fluid of women with endometriosis has also
pointed to an altered immunologic function possibly related
to infertility [16].
Purinergic signalling, the group of biologic effects exerted
by extracellular nucleotides such as ATP and nucleosides
such as adenosine through specific receptors, is an impor-
tant regulatory mechanism in a wide range of inflamma-
tory conditions [17, 18]. ATP is a “danger signal” released
under tissue stress conditions, such as necrosis, apoptosis,
hypoxia, and inflammation and is rapidly converted into
adenosine, which protects cells and tissues from excessive
inflammation and immune-mediated damage. The effects
transduced by both molecules are thus often opposite, and
the resulting cellular responses are the consequence of the
ratio of ATP (and ADP) to adenosine concentrations, which
is mainly controlled by ecto-nucleotidases, key enzymes in
the purinergic signalling [19]. The most well-characterized
ectonucleotidase pathway involves the sequential action of
CD39 (ectonucleoside triphosphate diphosphohydrolase-1,
NTPDase1), which converts extracellular ATP (or ADP)
to AMP, and CD73 (ecto-5󸀠-nucleotidase), which generates
adenosine from AMP [20–23]. We have previously char-
acterized the expression of endometrial ecto-nucleotidases,
demonstrating changes along the cycle and in menopause
[24, 25]. We have also demonstrated that CD39 and CD73
are highly expressed in endometrial cancer [26], contributing
to the increased immunosuppressive levels of extracellular
adenosine found in tumor microenvironment.
Exosomes are small, secreted membrane vesicles (30–
100 nm in diameter) of endocytic origin, produced by many
different cell types that are formed by the fusion ofmultivesic-
ular endosomeswith the plasmamembrane.They are thought
to play an important role in intercellular communication, for
example, during immune cell-cell interaction, and have been
identified in biological fluids, such as plasma and urine, as
well as in cell culture supernatants [27, 28]. The presence of
the ecto-nucleotidases CD39 and CD73 has been previously
demonstrated in cancer exosomes [29–31], contributing to
the adenosine production that suppresses T-cell function.
In the present work, we aimed to determine whether
ecto-nucleotidases activities (ATPase, ADPase, and AMPase)
are present and measurable in the ultrasound-guided aspi-
rated contents of ovarian cysts and whether these activities
are altered in endometriotic cysts compared with simple
cysts, affecting the inflammatory condition of endometriosis.
Our goal is to evaluate their potential as biomarkers for
endometriosis and to contribute to the knowledge of the
physiopathologic mechanisms underlying endometriosis.
2. Materials and Methods
2.1. Samples. The ethical principles of this study adhere to the
Declaration ofHelsinki, and all the procedureswere approved
by the ethics committee for clinical investigation of Bellvitge
Hospital. A prospective cohort of 27 adnexal cysts with a
low risk of malignancy, including 14 endometriomas and 13
ovarian simple cysts, was studied at the Gynecology Service
of Bellvitge Hospital (Barcelona, Spain) between March 2013
and April 2014.
Inclusion criteria in the study for patients were (1) aged
>18 years old; (2) ultrasound features predictive of a low
risk of cyst malignancy: smooth walls, no solid component,
maximum diameter between 40 and 100mm, no more than
one thin septation (<2-3mm), and no internal flow on color
Doppler imaging in the case of bilocular cysts, according to
IOTA criteria [32]; (3) cyst persistence from diagnosis ≥6
months; (4) tumor marker Ca 125 < 200 IU/mL and Ca
19.9 < 35 IU/mL; and (5) written informed consent from the
patients.
For ultrasound-guided aspiration, following the abdo-
men, or the vagina, disinfection, a sterilized 17G spinal needle
(BD Medical Franklin Lakes, NJ Becton, Dickinson and
Company) was aimed at the center of the cyst under direct
ultrasound guidance and the contents was aspirated. When
thick highly dense intracystic fluid was present, in order
to facilitate the aspiration, saline dilutions were performed.
Dilutionsmadewere then considered in the final calculations.
Then, several intracyst saline washes were performed until
clearance, followed by the instillation of ethanol as sclerosing
agent.Thevolume of instilled ethanol was 2/3 of the aspirated
volume of the endometrioma and always less than 100mL.
Ethanol was left inside the cyst for 15min and then removed
and washed out again with a saline solution. The intracystic
fluids were analyzed cytologically at the Pathology Service of
Bellvitge Hospital to confirm the absence of atypical cells.
Patients were divided into two groups following the
ultrasound features and internal color fluid: (a) endometri-
omas group that had homogeneous appearance involving
diffuse internal echoes on a hypoechoic background and
contained blood color fluid and (b) simple cysts group that
had an anechoic structure and contained clear serous fluid.
Table 1 includes the descriptive statistics of the two groups of
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Table 1: Descriptive statistics of the two groups of patients and samples.
Age (years) Size (mm) Volume (mL)
Simple cyst (𝑁 = 13)
Mean (SD) 39,8 (13,5) 69,54 (14,02) 69,85 (59,36)
Range 20–64 49–98 20–248
Endometrioma (𝑁 = 14)
Mean (SD) 38,6 (14,1) 73,71 (33,26) 112,50 (111,77)
Range 28–84 42–170 20–410
The size represents the largest cystic diameter measured on ultrasound. The volume represents the total aspirated volume of intracystic fluid (SD: standard
deviation).
patients, including the age and the size and the volume of the
cysts.
An aliquot of each sample was maintained on ice until
usage for exosome enrichment. The rest was aliquoted and
stored at −80∘C.
2.2. Exosome Enrichment. Endometriomas and simple cysts
fluid samples were centrifuged at 3000×g for 15min to
remove cells and cell debris, and supernatants were trans-
ferred to sterile tubes. 250 𝜇L of each supernatant was mixed
with 63 𝜇L of ExoQuick Exosome Precipitation Solution
(SystemBiosciences,MountainView, CA,USA) by inversion,
and the mixture was refrigerated overnight at 4∘C, following
the supplier’s instructions. Samples were then centrifuged
at 1500×g for 30min. After centrifugation, the exosomes
appeared as a beige or white pellet at the bottom of the
tube. Supernatant was aspirated and the residual ExoQuick
solution was spun down by centrifugation at 1500×g for
5min. All traces of fluid were removed by aspiration and
exosome pellets were resuspended in two different buffers.
For Western blot analysis, exosome pellets were resuspended
in 75 𝜇L of a buffer containing 10mM Tris-HCl pH 7.4,
150mMNaCl, and 1 : 100 proteases inhibitor cocktail (Sigma-
Aldrich, Saint Louis, MO, USA). Alternatively, for ecto-
nucleotidases activity assays, exosome pellets were resus-
pended in 75𝜇Lof enzyme assay buffer (160mMTris-HCl pH
7.4, 10mMCaCl
2
). Protein concentration in exosome samples
was determined by the method of Bradford [33]. Samples
were stored at −20∘C until usage.
2.3. Western Blotting Analysis. 15 𝜇g of protein was heated at
95∘C for 3min, loaded onto any kD Mini-PROTEAN TGX
Precast Gel (Bio-Rad, Hercules, CA, USA), and transferred to
polyvinylidene fluoride (PVDF)membranes using the Trans-
Blot Turbo Transfer System (Bio-Rad). Blots were blocked
with Tris-buffered saline with 0.1% Tween-20 (TBS-T) con-
taining 5% nonfat dry milk for 1 hour at room temperature
(RT). Membranes were then incubated overnight at 4∘C with
the following antibodies: exosomal marker antibodies CD9,
CD63, CD81, HSP70 (diluted 1 : 1000) from the ExoAB-KIT-
1 Western blot antibody detection kit (System Biosciences),
anti-CD39 (clone BU61, diluted 1 : 500), and anti-CD73 (clone
4G4 fromAbcam, diluted 1 : 50). Blots were then washed with
TBS-T and incubated with the appropriate HRP-conjugated
secondary antibody (System Biosciences, dilution 1 : 20,000)
for 1 hour at RT. Membranes were then incubated with
Amersham ECL Western Blotting Detection Reagents (GE
Healthcare, Pittsburgh, PA, USA) for 1min and exposed on
X-ray films.
2.4. Nucleotidase Activity Assays. Nucleotidase activities
(ATPase, ADPase, and AMPase) were determined in flat-
bottom 96-well plates by measuring the amount of liberated
inorganic phosphate (Pi) using the malachite green colori-
metric assay [34]. All the samples were used for these assays.
The incubation mixture contained 160mM Tris–HCl pH 7.4,
10mM CaCl
2
, 5mM levamisole, as alkaline phosphatases
inhibitor, and 1mM ATP, ADP, or AMP as substrates in a
final volume of 150 𝜇L. The assay was initiated by adding
the sample, either the fluid directly (5𝜇L for ATPase and
ADPase assays and 10 𝜇L for AMPase assay) or 50 𝜇g of the
isolated exosome fraction. Alternatively, increasing amounts
of exosomes were added to the well to assess if ectonucleoti-
dase activity depended on the exosome dose (5, 10, 15, 20,
30, and 50 𝜇g). After 20minutes of incubation at 37∘C, 50 𝜇L
of malachite green solution was added to each well and 10
and 20minutes later, the OD
620
was measured and recorded.
Incubation times and protein concentrations were chosen to





used as a Pi standard. Controls to determine nonenzymatic
Pi accumulation were performed by incubating either the
samples in the absence of the substrate or the substrate
alone. Each experiment was performed three times and in
each experiment samples were analyzed in triplicate. Enzyme
activity was expressed as pmols Pi/min/𝜇L in the case of the
whole fluids and as pmol Pi/min/𝜇g for exosomes.
2.5. ElectronMicroscopy Studies. For morphological analysis,
whole-mount electron microscopy preparations of exosomes
were obtained as previously described by The´ry et al. [35].
In brief, exosome-containing pellets were resuspended in
2% paraformaldehyde in 100mM phosphate-buffered saline
(PBS). 5 𝜇L of resuspended pellets was deposited on formvar-
coated grids and incubated at RT for 20min. After thorough
rinses, the samples were postfixed in 1% glutaraldehyde for
5min and then contrasted in a solution of 2% uranyl acetate,
150mM oxalic acid pH 7.Then the grids were transferred to a
drop of 1.8% methyl-cellulose, 0.4% uranyl acetate for 10min
on ice. Finally, the grids were removed with stainless steel
loops and air-dried for additional 10min.
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(a) (b)
Figure 1: Transvaginal ultrasound-guided aspiration of an endometrioma. (a) Endometrioma measured before aspiration. Dotted line
indicates one of the diameter measurements. (b) Endometrioma being aspirated. The arrow indicates the end of the needle inside the cyst.
Note the reduction in the volume after aspiration.
Alternatively, and in order to obtain thin sections,
the paraformaldehyde-fixed exosome-containing pellets were
postfixed in 2.5% glutaraldehyde and 2% paraformaldehyde
in 100mM PBS, dehydrated in a graded ethanol series, and
embedded in the Spurr low viscosity resin. Ultrathin sections
(50–60 nm) from exosome-enriched pellets were cut with
a diamond knife in an ultramicrotome UltracutE (Leica
Microsystems). After being picked up on copper grids, the
ultrathin sections were stained with uranyl acetate and lead
citrate. Finally, exosomes were observed with a JEM-1010
transmission electron microscope (JEOL, Japan), and the
images were recorded with a Bio Scan 792 camera (GATAN,
Germany).
2.6. Statistical Analysis. Statistical analysis was performed
using SigmaStat 3.2 software (SPSS Inc., Chicago, IL, USA).
Values are reported as the mean ± S.E.M. Student’s 𝑡-test was
used to compare the means of two independent groups of
normally distributed data.
3. Results and Discussion
Most of the attempts to identify peripheral biomarkers of
endometriosis have been focused on their presence in plasma,
serum, or urine [3]. However, the study of endometriomas
contents has been proven to be very informative [15, 16].
In the present work, we have evaluated the ectonucleotidase
enzyme activities present in endometriomas in comparison
with ovarian simple cysts.
Echo-guided aspirationwas the technique used to remove
the fluid contained in endometriomas and simple cysts.
Immediate ethanol sclerosis was performed to chemically
destroy the cyst lining and to prevent its regrowth. Figure 1
shows the ultrasound picture of an endometrioma before and
during the aspiration of its contents.
Aspirated fluids were then used for enzyme activity
studies. Ecto-nucleotidases activities (ATPase, ADPase, and,
to a lesser extent, AMPase) were present and quantifi-
able in the aspirated fluid of both endometriomas and



























Figure 2: Enzyme activity in fluids from simple cysts and from
endometriomas. Ectonucleotidase activity, represented as pmoles of
generated Pi, in fluids from simple cysts (white columns) and from
endometriomas (gray columns) in the presence of ATP, ADP, or
AMP as substrate. ATPase and ADPase activities are significantly
higher in endometriomas than in simple cysts (∗∗∗
𝑃
< 0, 001), while
AMPase activity was barely detectable and differences could not be
determined.
showed significantly higher (𝑃 < 0, 001) ATPase and
ADPase activities (mean ± SEM, 38,96 ± 5,11 and 33,68 ±
3,95 pmol/min/𝜇L, resp.) than simple cysts (7,19 ± 1,88 and
1,55 ± 0,4 pmol/min/𝜇L, resp.). Low activity rates were
detected with AMP as substrate in the aspirated fluid and
although endometriomas displayed higher AMPase activ-
ity (1,28 ± 0,46 pmol/min/𝜇L) than simple cysts (0,87 ±
0,25 pmol/min/𝜇L), differences were not significant. The
same results were also obtained when the activities were
calculated per 𝜇g of protein in the fluid, with even higher
activities in endometriomas (data not shown); however, since
it is known that endometriotic cysts differ from simple
cysts in protein contents [16], results are shown here as Pi





























Figure 3: Exosome characterization. (a) Representative TEM images of exosomes isolated from endometriomas (bar = 25 nm). (b) Western
blot with four different exosome markers: CD63 (A), Hsp70 (B), CD81 (C), and CD9 (D) of exosome-enriched fractions from simple cysts
(SC) and from endometriomas (EM). The figure shows one representative experiment of each type of the sample. Molecular weight markers
in kDa are indicated at the left of each image.
generation per unit of volume.This is the first time that ecto-
nucleotidases have been studied in ovarian cysts, although
these enzyme activities have been previously characterized
in other fluids such as pancreatic juice [36] and plasma
[37], where there is a correlation between their activity and
different inflammatory pathologies [38].
Since to perform the enzyme activity assays, aspirated
fluids were previously centrifuged to remove cells and cell
debris, the resulting activities could be attributed either to
soluble enzymes or to membrane bound ecto-nucleotidases
present in extracellularmembrane vesicles such asmicrovesi-
cles and exosomes that were not removed by the initial
centrifugation. Therefore, we decided to perform exosome
enrichment to assess their presence and to determine if they
had ectonucleotidase activities. To our knowledge, this is
the first study demonstrating the presence of exosomes in
the fluids contained in ovarian cysts. Electron microscopy
analysis confirmed the size and morphology of exosomes
(Figure 3(a)). Western blots using antibodies against four
exosome markers (CD9, CD63, CD81, and Hsp70) demon-
strated the presence of these structures in 100% of endometri-
omas and in 46% of simple cysts aspirates (Figure 3(b)). From
these experiments, we conclude that, among the markers
used, CD9 is the most suitable for exosome demonstration
in the aspirated fluids of ovarian cysts, since it was present
in all exosome samples analyzed. CD9 has been already
demonstrated to be a good exosome marker for epithelial
endometrial cells [39, 40]. All the samples expressed, together
with CD9, at least one more of the other exosome markers
assayed. Interestingly, using the anti-CD63 antibody, the pre-
dominant band in endometriomas was of a lower molecular
weight than in simple cysts. A possible explanation is the


























































Figure 4: Enzyme activity in exosome-enriched fractions from simple cysts and from endometriomas. (a) ATPase (black circles) and ADPase
(white circles) activities of increasing amounts of exosomes from endometriomas (0, 5, 10, 20, 30, and 50𝜇g). (b) Ectonucleotidase activity,
represented as pmoles of generated Pi, in exosome-enriched fractions from simple cysts (white columns) and from endometriomas (gray
columns) in the presence of ATP, ADP, or AMP as substrate. All the activities are significantly higher in endometriomas than in simple cysts
(∗∗∗
𝑃
< 0, 001). (c)Western blot with anti-CD39 and anti-CD73 antibodies of exosome-enriched fractions from an endometrioma.Molecular
weight markers in kDa are indicated at the left of each image.
alternative splicing already described for the gene encoding
CD63 that results in multiple transcript variants encoding
different proteins. Since this result was consistent in all the
samples studied, we propose to further study its presence in
exosomes from other origins in endometriosis patients, to
establish if it could be used as biomarker for the pathology.
Enzyme experiments performed with exosome-enriched
fractions demonstrated that these samples retain the ectonu-
cleotidase activity (ATPase, ADPase, and AMPase) displayed
by the whole fluid. Moreover, these activities are dependent
on the sample dose, as shown in Figure 4(a), in line with
previous results obtained with exosomes from other origins
that express active CD39 and CD73 [29]. For ATPase and
ADPase, maximal activity was found with 50𝜇g of exosomes.
AMPase activity, which was barely detectable in the whole
fluid, was present in purified exosomes, though only at high
concentrations (50𝜇g), indicating that this activity in the
whole fluid is mainly due to the enzymes bearing exosomes.
On the contrary, ATPase and ADPase activities would be
related to both exosome membrane bound and soluble
enzymes. Figure 4(b) shows the enzyme activity using ATP,
ADP, and AMP as substrates of exosomes from simple cysts
and from endometriomas. These activities were significantly
higher in endometriomas than in simple cysts. Western blot
analysis demonstrated the presence of CD39 and CD73 in
these samples (Figure 4(c)).
Our results reinforce the emerging evidence linking
inflammation to endometriosis pathophysiology, where eva-
sion of the immune surveillance seems to be crucial in the ini-
tial establishment and subsequent development of displaced
endometrial tissues [41]. In this sense, increased sequentially
acting ectonucleotidase activities would contribute to the
maintenance of the suppression of local immune responses
necessary for the disease progression, by regulating extra-
cellular ATP and rising extracellular adenosine levels. We
propose to detect their presence in other more accessible
biological fluids, a fact that, together with the simplicity of
their detection, would make them promising endometriosis
biomarkers.
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4. Conclusions
Our work contributes to the knowledge of endometriosis by
providing new data on the fluid composition of endometri-
omas. Ecto-nucleotidases activities are quantifiable in the
ovarian cysts aspirates, and they are significantly increased in
the contents of endometriomas compared with simple cysts.
Moreover, the identification of ecto-nucleotidases bearing
exosomes in ovarian cyst contents opens the field for a broad
range of proteomics and genomics studies.
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